Table 2.
Run | PL concentration (X1, mg/mL) | MEL concentration (X2, mg/mL) | Particle size (Y1, nm) | Zeta potential (Y2, mV) | Entrapment efficiency (Y3, %) |
---|---|---|---|---|---|
1 | 40 | 10 | 243 | –10.6 | 78.7 |
2 | 60 | 5 | 275 | –19.3 | 84.6 |
3 | 40 | 10 | 241 | –9.9 | 77.7 |
4 | 20 | 10 | 175 | –1.4 | 73.7 |
5 | 20 | 15 | 188 | 3.1 | 74.7 |
6 | 40 | 10 | 239 | –10.9 | 76.8 |
7 | 20 | 5 | 156 | –4.6 | 74.6 |
8 | 40 | 10 | 242 | –10.3 | 77.5 |
9 | 60 | 15 | 319 | –14.1 | 88.8 |
10 | 40 | 5 | 216 | –12.8 | 74.8 |
11 | 60 | 10 | 298 | –16.5 | 87.4 |
12 | 40 | 10 | 244 | –9.7 | 77.4 |
13 | 40 | 15 | 265 | –8.1 | 76.9 |
RLX: raloxifene; PL: phospholipid; MEL: melittin.